Clozapine

规格

5786-21-0CAS 号

227-313-7EC 号

3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepineIUPAC 名称

C18H19ClN4化学式

326.8 g/mol分子量

clozapine; 5786-21-0; Leponex; Clozapin; CLOZARIL; Fazaclo; Clorazil; Clozapina; Clozapinum; HF-1854; Fazaclo ODT; HF 1854; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; Versacloz; DTXSID5022855; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-; J60AR2IKIC; Clozapine (udl); Clozapine (ivax); Clozapine (teva); Clozapine (mylan); Clozapine (caraco); Clozapine (fazaclo); NSC-757429; Clozapine (Clozaril); Clozapine (versacloz); 5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine; CHEBI:3766; DTXCID302855; Zaponex; 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo(b,e)(1,4)diazepine; 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,9,12,14-heptaene; 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,9,12,14-heptaene; RefChem:5701; N05AH02; 227-313-7; 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaene; Clonex; Iprox; Lepotex; W-801; MFCD00153785; 3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine; CHEMBL42; MLS000028472; Asaleptin; NCGC00015254-12; SMR000058365; CAS-5786-21-0; 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; Clozapinum [INN-Latin]; Clozapina [INN-Spanish]; Azaleptine; Clozaril (TN); 1333667-72-3; CCRIS 9171; HSDB 6478; SR-01000000096; EINECS 227-313-7; UNII-J60AR2IKIC; 3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine; BRN 0764984; Clozapine (JAN/USP/INN); Azaleptin;; Alemoxan;; Clozaril;; Lapenax;; Leponex;; LX 100-129; Clozapine CRS; Clozapine, solid; Iprox;; LEX-123; Clozapine [USAN:USP:INN:BAN]; 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine; Prestwick_693; Clozapine (Standard); KS-1166; Spectrum_000139; Tocris-0444; CPD000058365; CLOZAPINE [INN]; CLOZAPINE [JAN]; Opera_ID_482; CLOZAPINE [MI]; CLOZAPINE [HSDB]; CLOZAPINE [USAN]; Prestwick0_000350; Prestwick1_000350; Spectrum2_000919; Spectrum3_001828; Spectrum4_000898; CLOZAPINE [VANDF]; Lopac-C-6305; CLOZAPINE [MART.]; GTPL38; C 6305; CLOZAPINE [USP-RS]; CLOZAPINE [WHO-DD]; SCHEMBL8397; REGID_for_CID_2818; SCHEMBL33323; KBioGR_000310; KBioGR_001336; KBioSS_000310; KBioSS_000599; MLS001077282; DivK1c_000343; SPECTRUM1500685; Clozapine - Bio-X trade mark; SPBio_000798; SPBio_002340; Clozapine, 1mg/ml in Methanol; CHEMBL253391; orb1224602; orb1310596; orb3141245; CLOZAPINE [ORANGE BOOK]; PS04 - Clozapine/Norclozapine; CLOZAPINE [EP MONOGRAPH]; SCHEMBL29360001; SCHEMBL29433929; SCHEMBL29590817; BDBM22869; CHEBI:92657; HMS501B05; KBio1_000343; KBio2_000310; KBio2_000599; KBio2_002878; KBio2_003167; KBio2_005446; KBio2_005735; KBio3_000619; KBio3_000620; KBio3_002979; CLOZAPINE (UDL) [VANDF]; CLOZAPINE [USP MONOGRAPH]; CLOZAPINE (IVAX) [VANDF]; CLOZAPINE (TEVA) [VANDF]; NINDS_000343; Bio1_000436; Bio1_000925; Bio1_001414; Bio2_000310; Bio2_000790; DTXSID401020663; GLXC-06516; HMS1361P12; HMS1569E21; HMS1791P12; HMS1921C16; HMS1989P12; HMS2089L13; HMS2092I16; HMS2096E21; HMS2235E19; HMS3259J17; HMS3260H14; HMS3266A10; HMS3371H05; HMS3402P12; HMS3414F09; HMS3657E15; HMS3678F09; HMS3713E21; HMS3742K03; HMS5081G07; Pharmakon1600-01500685; CLOZAPINE (MYLAN) [VANDF]; CLOZAPINE (CARACO) [VANDF]; KXB05350; CLOZAPINE (FAZACLO) [VANDF]; Tox21_110113; Tox21_500276; BDBM50001884; CCG-39881; EBC-00671; HB1607; HY-14539R; MSK000866; NSC757429; s2459; CLOZAPINE (CLOZARIL) [VANDF]; Clozapine 1.0 mg/ml in Acetonitrile; Clozapine for peak identification CRS; 8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methylpiperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine; AKOS005064444; AKOS026749900; CLOZAPINE (VERSACLOZ) [VANDF]; Tox21_110113_1; CS-0644; DB00363; FC20526; LP00276; NC00667; NSC 757429; SDCCGSBI-0050264.P005; NCGC00015254-01; NCGC00015254-02; NCGC00015254-03; NCGC00015254-04; NCGC00015254-05; NCGC00015254-06; NCGC00015254-07; NCGC00015254-08; NCGC00015254-09; NCGC00015254-10; NCGC00015254-11; NCGC00015254-13; NCGC00015254-14; NCGC00015254-15; NCGC00015254-16; NCGC00015254-17; NCGC00015254-18; NCGC00015254-20; NCGC00015254-31; NCGC00022902-02; NCGC00022902-04; NCGC00022902-05; NCGC00022902-06; NCGC00022902-07; NCGC00022902-08; NCGC00022902-09; NCGC00022902-10; NCGC00022902-11; NCGC00022902-12; NCGC00022902-13; NCGC00188978-01; NCGC00260961-01; BC164328; HY-14539; SY052613; SBI-0050264.P004; DB-053121; C2547; C4757; D-107; EU-0100276; NS00000413; SW220247-1; EN300-52510; C06924; D00283; H10436; M01464; AB00052158-13; AB00052158-14; AB00052158_15; AB00052158_16; Clozapine, drug standard, 1.0 mg/mL in methanol; L000195; L013417; Q221361; SR-01000000096-2; SR-01000000096-4; SR-01000000096-5; SR-01000000096-8; BRD-K37289225-001-09-1; BRD-K37289225-001-23-2; BRD-K37289225-001-34-9; BRD-K37289225-001-35-6; BRD-K37289225-001-36-4; BRD-K37289225-001-37-2; Clozapine, British Pharmacopoeia (BP) Reference Standard; Z754926488; Clozapine, European Pharmacopoeia (EP) Reference Standard; Clozapine, United States Pharmacopeia (USP) Reference Standard; 8-Chloro-11-(4-methyl-1-piperazinyl)-5/H-dibenzo[b,e]diazepine; 8-Chloro-11-(4-methylpiperazino)-5H-dibenzo[b,e][1,4]diazepine; 3-chloro-6-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine; 8-Chloro-11-(4-methyl-1-piperazinyl)-10H-dibenzo[b,e][1,4]diazepine; 8-chloro-11-(4-methyl-piperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine; 3-Hydroxy-2-phenyl-propionic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester; 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine (Clozapine); 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine( Clozepine ); 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Ciozapine); 8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Clopazine); Clozapine for peak identification, European Pharmacopoeia (EP) Reference Standard; CLOZAPINE, 8-CHLORO-11-(4-METHYL-PIPERAZIN-1-YL)-5H-DIBENZO[B,E][1,4]DIAZEPINE; 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0,3,8]pentadeca-1,3(8),4,6,10,12,14-heptaene; 6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1,3(8),4,6,10,12,14-heptaene同义词